CHEK1 and cancer: Considering their role as tumor suppressors as well as DNA damage response mediators, ATR and Chk1 have also been identified as cancer therapeutic targets (Awasthi et al., 2015; Qiu et al., 2018; Pilié et al., 2019; Carusillo and Mussolino, 2020).